Found 112 results
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Wu, Z., Tang, Z., Mao, Y., Van Veldhuisen, P., Ling, W., Liu, D., et al.. (2017). Testing and linkage to HIV care in China: a cluster-randomised trial. Lancet HIV, 4(12), e555-e565. presented at the 2017 12. doi:10.1016/S2352-3018(17)30131-5
Wu, L. - T., McNeely, J., Subramaniam, G. A., Brady, K. T., Sharma, G., VanVeldhuisen, P., et al.. (2017). DSM-5 substance use disorders among adult primary care patients: Results from a multisite study. Drug Alcohol Depend, 179, 42-46. presented at the 2017 10 01. doi:10.1016/j.drugalcdep.2017.05.048
Wright, J., Blatner, G. L., & Cheson, B. D.. (1999). Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777. Oncology (Williston Park), 13(11), 1527, 1530, 1533. presented at the 1999 Nov.
Wright, J. J., Blatner, G., & Cheson, B. D.. (1999). Clinical trials referral resource. Clinical trials of dolastatin-10. Oncology (Williston Park), 13(1), 68-70, 75. presented at the 1999 Jan.
Wright, J. J., Zerivitz, K., & Schoenfeldt, M.. (2003). Clinical trials referral resource. Current clinical trials of bortezomib. Oncology (Williston Park), 17(5), 677-80, 683-6, 691-2. presented at the 2003 May.
Wright, J. J., Zerivitz, K., Gravell, A. E., & Cheson, B. D.. (2002). Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra). Oncology (Williston Park), 16(7), 930-1, 935-7. presented at the 2002 Jul.
Wright, J., Blatner, G. L., & Cheson, B. D.. (1998). Clinical trials referral resource. Clinical trials of flavopiridol. Oncology (Williston Park), 12(7), 1018, 1023-4. presented at the 1998 Jul.
Wright, J., Hillsamer, V. L., Gore-Langton, R. E., & Cheson, B. D.. (2000). Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341. Oncology (Williston Park), 14(11), 1589-90, 1593-4, 1597. presented at the 2000 Nov.